Alterations of the basal membrana in middle ear cholesteatoma;Alteraciones de la membrana basal en el colesteatoma de oído medio

Acta Otorrinolaringologica Espanola

Volumn 52, Issue 4, 2001, Pages 330-335

  Bernal Sprekelsen, M ^a   Ebmeyer, J ^b   Anonopoulos, A ^b   Borkowski, G ^b   Sudhoff, H ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Basic fibroblastic growth factor; Cholesteatoma; Collagen type IV; Electron microscopy; Fibronectin; Immunohistochemistry; Metalloproteinases; Middle ear; Tenascin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 4; FIBRONECTIN; INTERSTITIAL COLLAGENASE; LAMININ; TENASCIN; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; AUDITORY CANAL; BASEMENT MEMBRANE; CHOLESTEATOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROSCOPY; OTITIS; TEMPORAL BONE; BASILAR MEMBRANE; CULTURE TECHNIQUE; FIBROBLAST; METABOLISM; MIDDLE EAR; PATHOLOGY; ULTRASTRUCTURE;

BASILAR MEMBRANE; CHOLESTEATOMA, MIDDLE EAR; COLLAGEN; CULTURE TECHNIQUES; EAR, MIDDLE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0035346357     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(01)78215-5     Document Type: Article

References (27)

1. Uitto J, Olsen DR, Fazio MJ. Extracellular matrix of the skin: 50 years of progress. J Invest Dermatol 1989; 92:61-74.
2. Eady EA. The basement membrane. Interface between epithelium and the dermis: structural features. Arch Dermatol 1988; 124:709-712.
3. Hay ED. Role of basement membranes in development and differentiation. In: Biology and chemistry of basement membranes. Kefalides, NA (Ed.) Academic Press, New York, 1978.
4. Clark RA, Folkvord JM, Wertz RL. Fibronectin, as well as other extracellular matrix proteins, mediate human keratinocyte adherence. J Invest Dermatol 1985; 84:378-383.
5. Crouch ED, Sage H, Bornstein P. Structural basis for apparent heterogeneity of collagens in human basement membranes: type IV procollagen contains two distinct chains. Proc Natl Acad Sci USA 1980; 77:745-749.
6. Grinnell F. Fibronectin and wound healing. J Cell Biochem 1984; 26:107-116, 1984.
7. Nagata H, Ueki H, Moriguchi T. Fibronectin. Arch Dermatol 1985; 121:995-999.
8. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986; 46:1-7.
9. Baird A, Böhlen, P. Fibroblast growth factors. In: Peptide growth factors and their receptors I. (Eds. MB Sporn, AB Roberts), Springer-Verlag, 1990:369-418.
10. Ries C, Petrides, PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995; 375:345-355.
11. Woessner JF. The family of matrix metalloproteinases. Ann N Y Acad Sci 1994; 732:11-21.
12. Sudhoff H, Bujia J, Holly A, Kim C, Fisseler-Eckhoff A. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 1994; 15: 217-221.
13. Sudhoff H, Bujia J, Fisseler-Eckhoff A, Schulz-Flake C, Kastenbauer E, Hildmann H. Expression of the cell-cycle-related antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995; 105:1227-1231.
14. Bernal M, Ebmeyer J, Buchbinder A, Sudhoff H. Análisis comparativo de la capacidad proliferativa del colesteatoma. Acta Otorrinolaringol Esp 2000; 51:299-307.
15. Hsu SM, Rainc L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80.
16. Palva T. The pathogenesis and treatment of cholesteatoma. Acta Otolaryngol (Stockh) 1990; 109:323-330.
17. Donaldson DJ, Mahan JT. Keratinocyte migration and extracellular matrix. J Invest Dermatol 1988; 90:623-628.
18. Stenn KS, Malhorta R. Epithelization. In: Wound healing - biochemical & clinical aspects. Cohen I, Diegelmann RF, Lindblad WJ. (Eds.), WB Saunders, Philadelphia, 115-27, 1992.
19. Sudhoff H, Bujia J, Fisseler-Eckhoff A, Borkowski G, Holly A, Koc C, Hildmann H. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations. Ann Otol Rhinol Laryngol 1996; 105:804-10.
20. Ergün S, Zheng X, Carlsöö B. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. Acta Otolaryngol 1994; 114:295-302.
21. Igisu K. The role of fibronectin in the process of wound healing. Throm Res 1986; 44:455-465.
22. Milewski C, Fedorowski A, Stan AC, Walter GF. Basic fibroblast growth factor - b-FGF- in the perimatrix of cholesteatoma. HNO 1998; 46:804-808.
23. Koutnouyan HA, Baird A, Ryan A. Acid and basic FGF mRNA expression in the middle ear mucosa during acute and chronic otits media. Laryngoscope 1994; 104:350-358.
24. Abramson M, Huang CC. Localization of collagenase in human middle ear cholesteatoma. Laryngoscope 1977; 87:771-779.
25. Banerjee AR, James R, Narula AA. Matrix metalloproteinase-9 in cholesteatoma and deep meatal skin. Clin Otolaryngol 1998; 23:345-347.
26. Banerjee AR, James R, Narula AA, Lee RJ. Matriz metalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis. Clin Otolaryngol 1998; 23:515-519.
27. Chole RA, Tinling SP. Basal lamina breaks in the histogenesis of cholesteatoma. Laryngoscope 1985; 95:270-275